Barta; Thomas E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barta; Thomas E..The latest application filed is for "compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9)".

Company Profile

13.27.43

Barta; Thomas E. - Carrboro NC
Barta; Thomas E - Carrboro NC
Barta; Thomas E. - Evanston IL
Barta; Thomas E - Evanston IL
Barta, Thomas E. - Chapel Hill NC
Barta, Thomas E. - Wilmette IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) App 20220267269 - Bowers; Simeon ; et al.	2022-08-25
Compounds For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) App 20220193058 - Bowers; Simeon ; et al.	2022-06-23
Composition And Methods Of Use Of Tetrahydroisoquinoline Small Molecules To Bind And Modulate Pcsk9 Protein Activity App 20210309613 - Barta; Thomas E. ; et al.	2021-10-07
Method To Treat Lipid Dysregulation By Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Protein Activity With Small Molecule Ligands App 20210275551 - Barta; Thomas E. ; et al.	2021-09-09
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity App 20210236481 - Barta; Thomas E. ; et al.	2021-08-05
Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands Grant 11,026,957 - Barta , et al. June 8, 2	2021-06-08
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Grant 10,980,801 - Barta , et al. April 20, 2	2021-04-20
Compounds For Binding Proprotein Convertase Subtilisin/kexin Type 9 App 20210032214 - Pandey; Anjali ; et al.	2021-02-04
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity Grant 10,865,185 - Barta , et al. December 15, 2	2020-12-15
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity Grant 10,821,106 - Barta , et al. November 3, 2	2020-11-03
Method To Treat Hypercholesterolemia By Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Protein Activity Wit App 20200253995 - Kind Code	2020-08-13
Phenylpiperazine Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Modulators And Their Use App 20200253958 - Kind Code	2020-08-13
Composition And Methods Of Use Of Tetrahydroisoquinoline Small Molecules To Bind And Modulate Pcsk9 Protein Activity App 20200207718 - Barta; Thomas E.	2020-07-02
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Grant 10,688,114 - Barta , et al.	2020-06-23
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Grant 10,568,882 - Barta , et al. Feb	2020-02-25
Composition and Methods of Use of Small Molecules as Binding Ligands for the Modulation of Proprotein Convertase Subtilisin/Kexi App 20190358248 - Barta; Thomas E ; et al.	2019-11-28
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Grant 10,307,433 - Barta , et al.	2019-06-04
Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels Grant 10,287,317 - Muehlemann , et al.	2019-05-14
Compounds For Binding Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) App 20190119236 - Pandey; Anjali ; et al.	2019-04-25
Composition And Methods Of Use Of Small Molecules As Binding Ligands For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9(pcsk9) Protein Activity App 20180303855 - Barta; Thomas E. ; et al.	2018-10-25
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity App 20180250291 - Barta; Thomas E. ; et al.	2018-09-06
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity App 20180237381 - Barta; Thomas E. ; et al.	2018-08-23
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Grant 10,034,892 - Barta , et al. July 31, 2	2018-07-31
Composition And Methods Of Use Of Small Molecules As Binding Ligands For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9(pcsk9) Protein Activity App 20170246196 - Barta; Thomas E. ; et al.	2017-08-31
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Allosteric Binding Ligands To Modulate Serum Low Density Lipoprotein (LDL) Levels App 20160083425 - Muehlemann; Michael M. ; et al.	2016-03-24
Tetrahydroindole and Tetrahydroindazole Derivatives App 20080269193 - Huang; Kenneth He ; et al.	2008-10-30
2, 8-disubstituted Naphthyridine Derivatives App 20080032991 - Hanson; Gunnar J. ; et al.	2008-02-07
2,8-disubstituted naphthyridine derivatives Grant 7,282,506 - Hanson , et al. October 16, 2	2007-10-16
Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives App 20070207984 - Huang; Kenneth He ; et al.	2007-09-06
Carbazole derivatives App 20070185184 - Hanson; Gunnar J. ; et al.	2007-08-09
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors Grant 7,119,203 - Barta , et al. October 10, 2	2006-10-10
Sulfonyl aryl or heteroaryl hydroxamic acid compounds Grant 7,115,632 - Bedell , et al. October 3, 2	2006-10-03
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20060084688 - Barta; Thomas E. ; et al.	2006-04-20
Methotrexate derivatives useful for treating cancer and arthritis App 20060035901 - Hanson; Gunnar J. ; et al.	2006-02-16
2,8-Disubstituted naphthyridine derivatives App 20060030584 - Hanson; Gunnar J. ; et al.	2006-02-09
Aromatic sulfone hydroxamic acids and their use as protease inhibitors App 20050101641 - Freskos, John N. ; et al.	2005-05-12
Aromatic sulfone hydroxamic acids and their use as protease inhibitors Grant 6,890,928 - Freskos , et al. May 10, 2	2005-05-10
Aromatic sulfone hydroxamic acid metalloprotease inhibitor Grant 6,890,937 - Barta , et al. May 10, 2	2005-05-10
Sulfonyl aryl or heteroaryl hydroxamic acid compounds App 20050075374 - Bedell, Louis J. ; et al.	2005-04-07
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors App 20050009838 - Barta, Thomas E. ; et al.	2005-01-13
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20040235818 - Barta, Thomas E. ; et al.	2004-11-25
Aromatic sulfone hydroxamic acids and their use as protease inhibitors App 20040209914 - Barta, Thomas E. ; et al.	2004-10-21
Sulfonyl aryl or heteroaryl hydroxamic acid compounds Grant 6,794,511 - Bedell , et al. September 21, 2	2004-09-21
Aromatic sulfone hydroxamic acid metalloprotease inhibitor Grant 6,750,233 - Barta , et al. June 15, 2	2004-06-15
Aromatic sulfone hydroxamic acid metalloprotease inhibitor Grant 6,750,228 - Barta , et al. June 15, 2	2004-06-15
Aromatic sulfone hydroxamic acids and their use as protease inhibitors App 20040110805 - Freskos, John N. ; et al.	2004-06-10
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20040048852 - Barta, Thomas E. ; et al.	2004-03-11
Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors Grant 6,696,449 - Barta , et al. February 24, 2	2004-02-24
Thioaryl sulfonamide hydroxamic acid compounds App 20040034071 - Getman, Daniel P. ; et al.	2004-02-19
Aromatic sulfone hydroxamates and their use as protease inhibitors Grant 6,689,794 - Freskos , et al. February 10, 2	2004-02-10
Aromatic sulfone hydroxamates and their use as protease inhibitors App 20040024024 - Freskos, John N. ; et al.	2004-02-05
Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors Grant 6,683,078 - Barta , et al. January 27, 2	2004-01-27
Aromatic sulfone hydroxamic acids and their use as protease inhibitors Grant 6,683,093 - Barta , et al. January 27, 2	2004-01-27
Aromatic sulfone hydroxamates and their use as protease inhibitors App 20040010019 - Freskos, John N. ; et al.	2004-01-15
Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds Grant 6,656,954 - Bedell , et al. December 2, 2	2003-12-02
Sulfonyl aryl or heteroaryl hydroxamic acid compounds App 20030191317 - Bedell, Louis J. ; et al.	2003-10-09
Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors App 20030171404 - Barta, Thomas E. ; et al.	2003-09-11
Aromatic sulfone hydroxamic acids and their use as protease inhibitors App 20030073718 - Barta, Thomas E. ; et al.	2003-04-17
Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors App 20030073845 - Barta, Thomas E. ; et al.	2003-04-17
4,5-subtstituted imdazolyl compounds for the treatment of inflammation App 20030050330 - Weier, Richard M. ; et al.	2003-03-13
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20020177588 - Barta, Thomas E. ; et al.	2002-11-28
Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds App 20020103239 - Bedell, Louis J. ; et al.	2002-08-01
4,5-substituted imidazolyl compounds for the treatment of inflammation Grant 6,426,360 - Weier , et al. July 30, 2	2002-07-30
Aromatic Sulfone Hydroxamic Acid Metalloprotease Inhibitor App 20010039287 - BARTA, THOMAS E ; et al.	2001-11-08
Sulfonyl Divalent Aryl Or Heteroaryl Hydroxamic Acid Compounds App 20010020021 - BEDELL, LOUIS J. ; et al.	2001-09-06
Aromatic Sulfone Hydroxamic Acid Metalloprotease Inhibitor App 20010014688 - BARTA, THOMAS E. ; et al.	2001-08-16
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives Grant 6,265,439 - Mueller , et al. July 24, 2	2001-07-24
Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation Grant 5,620,999 - Weier , et al. April 15, 1	1997-04-15
2-chloro and 2-bromo derivatives of 1,5-iminosugars Grant 5,595,981 - Barta , et al. January 21, 1	1997-01-21
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives Grant 5,451,604 - Mueller , et al. September 19, 1	1995-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.